4//SEC Filing
Cutler Adam D. 4
Accession 0000950170-23-071115
CIK 0001971543other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:30 PM ET
Size
7.5 KB
Accession
0000950170-23-071115
Insider Transaction Report
Form 4
Cutler Adam D.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-14+146,452→ 146,452 totalExercise: $3.61Exp: 2033-12-13→ Ordinary Shares (146,452 underlying) - Award
Ordinary Shares
2023-12-14+78,859→ 78,859 total
Footnotes (2)
- [F1]Consists of ordinary shares issuable under 78,859 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of October 30, 2023, subject to the reporting person's continued service with the Issuer.
- [F2]This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on October 30, 2024 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer.
Documents
Issuer
Mural Oncology plc
CIK 0001971543
Entity typeother
Related Parties
1- filerCIK 0001722673
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:30 PM ET
- Size
- 7.5 KB